BE748392A - Nouvelles phenylpyrrolidines, utiles notamment comme decontractants musculaires et anticonvulsifs, et leur procede de preparation - Google Patents

Nouvelles phenylpyrrolidines, utiles notamment comme decontractants musculaires et anticonvulsifs, et leur procede de preparation

Info

Publication number
BE748392A
BE748392A BE748392DA BE748392A BE 748392 A BE748392 A BE 748392A BE 748392D A BE748392D A BE 748392DA BE 748392 A BE748392 A BE 748392A
Authority
BE
Belgium
Prior art keywords
decontractants
phenylpyrrolidines
convulsive
muscle
useful
Prior art date
Application number
Other languages
English (en)
Inventor
G C Helsley
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of BE748392A publication Critical patent/BE748392A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BE748392D 1969-04-08 1970-04-02 Nouvelles phenylpyrrolidines, utiles notamment comme decontractants musculaires et anticonvulsifs, et leur procede de preparation BE748392A (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81444369A 1969-04-08 1969-04-08
US81444269A 1969-04-08 1969-04-08
US81549569A 1969-04-11 1969-04-11
US81549269A 1969-04-11 1969-04-11

Publications (1)

Publication Number Publication Date
BE748392A true BE748392A (fr) 1970-09-16

Family

ID=27505843

Family Applications (1)

Application Number Title Priority Date Filing Date
BE748392D BE748392A (fr) 1969-04-08 1970-04-02 Nouvelles phenylpyrrolidines, utiles notamment comme decontractants musculaires et anticonvulsifs, et leur procede de preparation

Country Status (10)

Country Link
US (4) US3635982A (fr)
AT (1) AT294815B (fr)
BE (1) BE748392A (fr)
CA (1) CA974995A (fr)
CH (2) CH549038A (fr)
DE (2) DE2017265A1 (fr)
FR (2) FR2042322B1 (fr)
GB (2) GB1299621A (fr)
NL (1) NL7005191A (fr)
SE (1) SE366040B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665754A (en) * 1993-09-20 1997-09-09 Glaxo Wellcome Inc. Substituted pyrrolidines

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2541855A1 (de) * 1975-09-18 1977-03-31 Schering Ag 4-(polyalkoxy-phenyl)-2-pyrrolidone ii
US4066772A (en) * 1975-07-21 1978-01-03 Janssen Pharmaceutica N.V. 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds
US4175129A (en) 1975-07-21 1979-11-20 Janssen Pharmaceutica N.V. Antiemetic 1-(benzoxazolylalkyl)-piperidine derivatives
US4035369A (en) * 1975-10-08 1977-07-12 Janssen Pharmaceutica N.V. 1-Benzazolylalkyl-4-substituted-piperidines
US4126687A (en) * 1976-05-17 1978-11-21 Janssen Pharmaceutica N.V. Antiemetic, 1-(benzimidazolyl-alkyl)-piperidine derivatives
LU75478A1 (fr) * 1976-07-28 1978-02-08
US4241061A (en) * 1979-05-21 1980-12-23 International Minerals & Chemical Corp. Oxazolidinyl-quinoxalines and use as growth promoters
US4303667A (en) * 1979-05-25 1981-12-01 Nippon Soda Company Limited Phenylprrole derivatives
EP0030526B1 (fr) * 1979-12-05 1985-02-27 Astra Läkemedel Aktiebolag Phényl-azacycloalcanes, procédés de préparation et préparations pharmaceutiques contenant ces composés
US4656276A (en) * 1980-08-07 1987-04-07 Angus Chemical Company Quinoxaline adducts useful as anthelmintics
US4661593A (en) * 1980-08-07 1987-04-28 Angus Chemcial Company Quinoxaline adducts useful as anthelmintics
US4720548A (en) * 1980-08-07 1988-01-19 Angus Chemical Company Quinoxaline adducts useful as anthelmintics
US4629790A (en) * 1980-08-07 1986-12-16 Angus Chemical Company Quinoxaline adducts useful as anthelmintics
US4348389A (en) * 1980-08-07 1982-09-07 International Minerals & Chemical Corp. Quinoxaline adducts useful as anthelmintics
US4658028A (en) * 1980-08-07 1987-04-14 Angus Chemical Company Quinoxaline adducts useful as anthelmintics
DE3328643A1 (de) * 1983-08-09 1985-02-21 Gödecke AG, 1000 Berlin 3-aryl-3-pyrrolin-derivate, verfahren zu deren herstellung sowie deren verwendung bei der bekaempfung von herz- und gefaesskrankheiten
US5118816A (en) * 1990-12-26 1992-06-02 American Cyanamid Company 2-aryl-5-(trifluoromethyl)-2-pyrroline compounds useful in the manufacture of insecticidal, nematocidal and acaricidal arylpyrroles
US5514678A (en) * 1992-03-26 1996-05-07 E. I. Du Pont De Nemours And Company Arthropodicidal 1,2,4-triazinyl amides
FR2723091B1 (fr) * 1994-07-29 1996-11-08 Esteve Labor Dr Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles
US6355659B1 (en) 1994-07-29 2002-03-12 Laboratorios Del Dr. Esteve, S.A. 4-(4-Chlorophenyl)-1236-tetrahydro-1(1H-124-triazol-1-yl)butty)pyrideine and salts thereof; pharmaceutical compositions and method of treating psychoses utilizing same
ES2201105T3 (es) * 1994-08-05 2004-03-16 Pfizer Inc. Derivados del bencimidazol con actividad dopaminergica.
US5883094A (en) * 1995-04-24 1999-03-16 Pfizer Inc. Benzimidazolone derivatives with central dopaminergic activity
US5889010A (en) * 1995-05-18 1999-03-30 Pfizer Inc. Benzimidazole derivatives having dopaminergic activity
DE19615232A1 (de) * 1996-04-18 1997-10-23 Merck Patent Gmbh Neue Carbamoylderivate und deren Verwendung als 5-HT ¶1¶¶A¶-Antagonisten
GB9801392D0 (en) * 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds
KR20050010515A (ko) * 2002-06-14 2005-01-27 머크 앤드 캄파니 인코포레이티드 유사분열 키네신 억제제
CA2486215A1 (fr) * 2002-06-14 2003-12-24 Merck & Co., Inc. Inhibiteurs de kinesine mitotique
AU2003287057B2 (en) * 2002-10-18 2008-08-21 Merck Sharp & Dohme Corp. Mitotic kinesin inhibitors
JP2007502773A (ja) * 2003-08-15 2007-02-15 メルク　エンド　カムパニー　インコーポレーテッド 有糸分裂キネシン阻害薬
US7465746B2 (en) * 2003-08-15 2008-12-16 Merck & Co., Inc. Fluorinated 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP
WO2005017190A2 (fr) * 2003-08-15 2005-02-24 Merck & Co., Inc. Inhibiteurs de kinesine mitotique
US7829589B2 (en) * 2005-06-10 2010-11-09 Elixir Pharmaceuticals, Inc. Sulfonamide compounds and uses thereof
CA2611493A1 (fr) * 2005-06-10 2006-12-21 Elixir Pharmaceuticals, Inc. Composes sulfonamide et leurs utilisations
FR2902790A1 (fr) * 2006-06-27 2007-12-28 Sanofi Aventis Sa Derives d'urees de piperidine ou pyrrolidine,leur preparation et leur application en therapeutique
KR20100038295A (ko) * 2007-06-05 2010-04-14 엔에스아베 필리알 아프 뉴로서치 스웨덴 아베 스베리게 피질 카테콜아민성 신경 전달의 조정자로서의 이치환된 페닐피롤리딘
DE602008006720D1 (de) * 2007-06-05 2011-06-16 Nsab, Filial Af Neurosearch Sweden Ab Neue disubstituierte phenylpyrrolidine als modulatoren der kortikalen katecholaminergen neurotransmission
TWI457122B (zh) 2007-07-20 2014-10-21 Orion Corp 作為用於治療周邊和中央神經系統疾病之alpha2C拮抗劑的2,3－二氫苯並[1,4]戴奧辛－2－基甲基衍生物
JP5716202B2 (ja) * 2008-11-24 2015-05-13 インテグレイティブ・リサーチ・ラボラトリーズ・スウェーデン・アーベー 皮質のカテコールアミン作動性神経伝達のモジュレーターとしての３−フェニル−３−メトキシピロリジン誘導体
JOP20190049A1 (ar) 2016-09-23 2019-03-20 Bial Portela & C? S A مثبطات دوبامين-b-هيدروكسيلاز
CA3082337A1 (fr) 2017-12-04 2019-06-13 Bial - Portela & Ca, S.A. Inhibiteurs de dopamine-b-hydroxylase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362956A (en) * 1965-08-19 1968-01-09 Sterling Drug Inc 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665754A (en) * 1993-09-20 1997-09-09 Glaxo Wellcome Inc. Substituted pyrrolidines

Also Published As

Publication number Publication date
DE2017255A1 (de) 1970-10-08
FR2042322B1 (fr) 1973-06-08
US3644414A (en) 1972-02-22
FR2042321A1 (fr) 1971-02-12
CH556336A (de) 1974-11-29
AT294815B (de) 1971-12-10
US3647790A (en) 1972-03-07
CA974995A (en) 1975-09-23
GB1299621A (en) 1972-12-13
US3635982A (en) 1972-01-18
CH549038A (de) 1974-05-15
FR2042321B1 (fr) 1974-03-22
NL7005191A (fr) 1970-10-13
US3634441A (en) 1972-01-11
SE366040B (fr) 1974-04-08
FR2042322A1 (fr) 1971-02-12
GB1289089A (fr) 1972-09-13
DE2017265A1 (de) 1970-10-15

Similar Documents

Publication Publication Date Title
BE748392A (fr) Nouvelles phenylpyrrolidines, utiles notamment comme decontractants musculaires et anticonvulsifs, et leur procede de preparation
BE836885A (fr) Nouvelles cyanoguanidylpyridines, utiles notamment comme hypotenseurs,et leur procede de preparation
BE833821A (fr) Nouvelles urethannoxazolidines, et leur procede de preparation
BE752512A (fr) Nouvelles polyaryl-ether-sulfones et leur procede de preparation
BE847090A (fr) 15-steroides, et leur procede de preparation
FR2319343A1 (fr) Nouvelles guanidines, leur procede de preparation et leur application
BE758608A (fr) Nouvelles ureidophenylguanidines leur procede de preparation etleur application comme fongicides
BE832126A (fr) 1-thiadiazolylimidazolidinones, leur procede de preparation et leurs utilisations
BE838440A (fr) Nouvelles o-amono-oximes, leur procede de preparation et leurs applications
BE843840A (fr) Nouvelles guanidines et thiourees, leur procede de preparation et leur utilisations
BE841862A (fr) Anthraquinone-bis-amidines, leur procede de preparation et leurs applications
BE758607A (fr) Nouvelles amidophenylguanidines, leur procede de preparation etleur application comme fongicides
BE832364A (fr) 17 alpha-hydroxy-1,3,5(10), 15-oestratetraenes et leur procede de preparation
BE841814A (fr) Guanidines et thiourees, leur procede de preparation et leurs utilisations
BE826992A (fr) Benzenesulfonyl-urees, leur procede de preparation et leurs applications
FR2299300A1 (fr) Trihalogeno-1,1,1-methyl-4-pentene-3-ols-2 et leur procede de preparation
BE751880A (fr) Nouvelles 3,6-epithia, epidithia ou epitetrathiapiperazine-2,5-diones, utiles notamment comme antifongiques et leur procede de preparation
BE751562A (fr) 4-pyrazolidinols 1,2-disubstitues et leur procede de preparation
BE771582A (fr) Nouvelles sulfonyl-2-(arylhydrazino)-2-imidazolines, leur procede de preparation et leur utilisation comme ectoparasiticides
BE835427A (fr) Nouveaux methylenesteroides, et leur procede de preparation
BE802328A (fr) Cyanophenoxyacetonitriles, leur procede de preparation et leur utilisation
BE777062A (fr) 3-sulfo-alkyl-6-hydroxy-pyridones-(2), leur procede de preparation et application
BE849571A (fr) Diurethannes, leur procede de preparation et leur utilisation
BE818021A (fr) Nouvelles diaminobenzophenones et leur procede de preparation
BE825805A (fr) Diaminoguanidines substituees, leur procede de preparation et leurs applications